Your browser doesn't support javascript.
loading
Development of a real-time in vivo dosimetry tool for electron beam therapy using a flexible thin film solar cell coated with scintillator powder.
Jeong, Seonghoon; An, Seohyeon; Kwon, Yong-Cheol; Pak, Sang-Il; Cheon, Wonjoong; Shin, Dongho; Lim, Young Kyung; Jeong, Jong Hwi; Kim, Haksoo; Lee, Se Byeong.
Afiliación
  • Jeong S; Proton Therapy Center, National Cancer Center, Goyang, Republic of Korea.
  • An S; Proton Therapy Center, National Cancer Center, Goyang, Republic of Korea.
  • Kwon YC; Department of Physics, Hanyang University, Seoul, Republic of Korea.
  • Pak SI; Department of Radiation Oncology, Samsung Medical Center, Seoul, Republic of Korea.
  • Cheon W; Proton Therapy Center, National Cancer Center, Goyang, Republic of Korea.
  • Shin D; Proton Therapy Center, National Cancer Center, Goyang, Republic of Korea.
  • Lim YK; Proton Therapy Center, National Cancer Center, Goyang, Republic of Korea.
  • Jeong JH; Proton Therapy Center, National Cancer Center, Goyang, Republic of Korea.
  • Kim H; Proton Therapy Center, National Cancer Center, Goyang, Republic of Korea.
  • Lee SB; Proton Therapy Center, National Cancer Center, Goyang, Republic of Korea.
Med Phys ; 50(1): 557-569, 2023 Jan.
Article en En | MEDLINE | ID: mdl-35993665
ABSTRACT

PURPOSE:

A real-time solar cell based in vivo dosimetry system (SC-IVD) was developed using a flexible thin film solar cell and scintillating powder. The present study evaluated the clinical feasibility of the SC-IVD in electron beam therapy.

METHODS:

A thin film solar cell was coated with 100 mg of scintillating powder using an optical adhesive to enhance the sensitivity of the SC-IVD. Calibration factors were obtained by dividing the dose, measured at a reference depth for 6-20 MeV electron beam energy, by the signal obtained using the SC-IVD. Dosimetric characteristics of SC-IVDs containing variable quantities of scintillating powder (0-500 mg) were evaluated, including energy, dose rate, and beam angle dependencies, as well as dose linearity. To determine the extent to which the SC-IVD affected the dose to the medium, doses at R90 were compared depending on whether the SC-IVD was on the surface. Finally, the accuracy of surface doses measured using the SC-IVD was evaluated by comparison with surface doses measured using a Markus chamber.

RESULTS:

Charge measured using the SC-IVD increased linearly with dose and was within 1% of the average signal according to the dose rate. The signal generated by the SC-IVD increased as the beam angle increased. The presence of the SC-IVD on the surface of a phantom resulted in a 0.5%-2.2% reduction in dose at R90 for 6-20 MeV electron beams compared with the bare phantom. Surface doses measured using the SC-IVD system and Markus chamber differed by less than 5%.

CONCLUSIONS:

The dosimetric characteristics of the SC-IVD were evaluated in this study. The results showed that it accurately measured the surface dose without a significant difference of dose in the medium when compared with the Markus chamber. The flexibility of the SC-IVD allows it to be attached to a patient's skin, enabling real-time and cost-effective measurement.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Electrones / Dosimetría in Vivo Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Electrones / Dosimetría in Vivo Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article